Churchill Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21M Sell
195,676
-1,016
-0.5% -$109K 0.23% 37
2025
Q1
$19.8M Sell
196,692
-559
-0.3% -$56.4K 0.25% 31
2024
Q4
$17.6M Buy
197,251
+549
+0.3% +$49K 0.19% 38
2024
Q3
$16.5M Buy
196,702
+4,169
+2% +$349K 0.19% 45
2024
Q2
$14.8M Buy
192,533
+2,211
+1% +$170K 0.17% 49
2024
Q1
$13M Buy
190,322
+5,343
+3% +$366K 0.16% 50
2023
Q4
$10.7M Sell
184,979
-1,058
-0.6% -$61.2K 0.16% 50
2023
Q3
$9.82M Sell
186,037
-169
-0.1% -$8.92K 0.17% 61
2023
Q2
$10.1M Sell
186,206
-1,703
-0.9% -$92.1K 0.17% 64
2023
Q1
$9.4M Buy
187,909
+875
+0.5% +$43.8K 0.19% 67
2022
Q4
$8.65M Buy
187,034
+3,785
+2% +$175K 0.21% 65
2022
Q3
$7.1M Sell
183,249
-3,075
-2% -$119K 0.19% 68
2022
Q2
$6.94M Buy
186,324
+1,025
+0.6% +$38.2K 0.17% 73
2022
Q1
$8.21M Buy
185,299
+25,879
+16% +$1.15M 0.14% 74
2021
Q4
$6.77M Buy
159,420
+12,026
+8% +$511K 0.09% 106
2021
Q3
$6.4M Buy
147,394
+8,596
+6% +$373K 0.1% 105
2021
Q2
$5.94M Buy
+138,798
New +$5.94M 0.09% 116
2017
Q4
Sell
-139,118
Closed -$4.06M 132
2017
Q3
$4.06M Sell
139,118
-1,515
-1% -$44.2K 0.1% 80
2017
Q2
$3.9M Sell
140,633
-2,296
-2% -$63.6K 0.1% 77
2017
Q1
$3.56M Sell
142,929
-14,479
-9% -$360K 0.1% 79
2016
Q4
$3.41M Sell
157,408
-11,188
-7% -$242K 0.11% 76
2016
Q3
$4.01M Sell
168,596
-12,730
-7% -$303K 0.16% 68
2016
Q2
$4.24M Sell
181,326
-10,950
-6% -$256K 0.28% 65
2016
Q1
$3.62M Sell
192,276
-17,631
-8% -$332K 0.25% 69
2015
Q4
$3.87M Buy
209,907
+12,633
+6% +$233K 0.18% 76
2015
Q3
$3.24M Buy
197,274
+12,025
+6% +$197K 0.26% 79
2015
Q2
$3.28M Buy
185,249
+10,759
+6% +$190K 0.12% 99
2015
Q1
$3.1M Buy
+174,490
New +$3.1M 0.11% 103